Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Xiayun Jin, Xiaofen Yi, Yuanliang Chen, Jiru Zhang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Therapeutic peptides to treat myocardial ischemia-reperfusion injury
10.3389/fcvm.2022.792885 · 2022
Myocardial ischemia-reperfusion injury; molecular mechanisms and prevention
10.1016/j.mvr.2023.104565 · 2023
Molecular and cellular mechanisms of cardioplegic protection in surgical myocardial revascularization
10.3390/cells15020173 · 2026
Molecular and cellular mechanisms of myocardial ischemia and reperfusion injury: a narrative review
10.3390/cells15030265 · 2026
Mitochondrial redox regulation and myocardial ischemia-reperfusion injury
2022
Resorcimoline protects against myocardial ischemia-reperfusion injury via suppression of oxidative stress
10.1253/circj.cj-25-0926 · 2026
Effect of inhibition of Na+/Ca2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death
10.1016/s0008-6363(02)00461-3 · 2002
Levistolide a alleviates myocardial ischemia-reperfusion injury partly by improving calcium homeostasis via the ADORA2B/cAMP/PKA/PLB/SERCA2α signaling axis
10.3390/cimb48020125 · 2026
Calpain: the regulatory point of myocardial ischemia-reperfusion injury
2023
Dynamin-related protein 1 is a critical regulator of mitochondrial calcium homeostasis during myocardial ischemia/reperfusion injury
10.1096/fj.202301040rr · 2024
Dantrolene induces mitigation of myocardial ischemia-reperfusion injury by ryanodine receptor inhibition
10.1053/j.semtcvs.2021.01.004 · 2022
2-aminoethoxydiphenylborane intervenes intracellular calcium signaling and attenuates myocardial ischemia-reperfusion injury in mice through ITPR1/MCU pathway
10.1038/s41598-025-14822-2 · 2025
The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis
10.1016/j.gene.2013.05.041 · 2013
Inflammation in myocardial ischemia/reperfusion injury: underlying mechanisms and therapeutic potential
2023
Myeloid cells in myocardial ischemic injury: the role of the macrophage migration inhibitory factor
2024
Ozone protects from myocardial ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome
10.1016/j.ejphar.2025.177631 · 2025
Macrophage polarization in myocardial ischemia–reperfusion injury: pathophysiology and therapeutic targets
10.2147/dddt.s516001 · 2025
Regulated cell death in myocardial ischemia-reperfusion injury
10.1016/j.tem.2023.10.010 · 2024
Targeting programmed cell death in myocardial ischemia-reperfusion injury: potential mechanisms and natural medicine treatments
10.1002/ptr.70269 · 2026
Iguratimod alleviates myocardial ischemia/reperfusion injury through inhibiting inflammatory response induced by cardiac fibroblast Pyroptosis via COX2/NLRP3 signaling pathway
2021
PIM3 regulates myocardial ischemia/reperfusion injury via ferroptosis
10.1007/s13258-023-01475-6 · 2024
Carnosic acid protects against mitochondrial dysfunction and ferroptosis in myocardial ischemia/reperfusion injury through mediating Mfn2
10.1016/j.ejphar.2026.178690 · 2026
Cardiomyocyte-specific Piezo1 deficiency mitigates ischemia-reperfusion injury by preserving mitochondrial homeostasis
10.1016/j.redox.2024.103471 · 2025
The myocardial ischemic cascade network and multi-target synergistic interventions: from molecular mechanisms to therapeutic innovations
10.1016/j.bcp.2026.117704 · 2026
Myocardial ischemia-reperfusion injury-mechanistic insights and novel therapeutics
10.3390/ijms27052106 · 2026
Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective
10.1080/10717544.2023.2298514 · 2024
Nanodrug targeting for myocardial ischemia-reperfusion injury: mechanisms, therapeutic strategies, and challenges in clinical translation
10.1016/j.ijpharm.2025.126153 · 2025
Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury
10.1016/j.jconrel.2022.11.057 · 2023
CIRKIL exacerbates cardiac ischemia/reperfusion injury by interacting with Ku70
10.1161/circresaha.121.318992 · 2022
Ubiquitin-specific protease 11 aggravates ischemia-reperfusion-induced cardiomyocyte Pyroptosis and injury by promoting TRAF3 Deubiquitination
10.4274/balkanmedj.galenos.2023.2022-12-15 · 2023
SerpinA3 promotes myocardial infarction in rat and cell-based models
10.1007/s12033-023-00982-x · 2025
Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice
10.1038/s41598-020-72325-8 · 2020
Mitochondrial disorder and treatment of ischemic cardiomyopathy: potential and advantages of Chinese herbal medicine
10.1016/j.biopha.2022.114171 · 2023
TBC1D15-Drp1 interaction-mediated mitochondrial homeostasis confers cardioprotection against myocardial ischemia/reperfusion injury
10.1016/j.metabol.2022.155239 · 2022
Cellular mechanisms and pathways in myocardial reperfusion injury
10.1097/mca.0000000000000997 · 2021
The roles of neutrophils in cardiovascular diseases
10.3389/fcvm.2025.1526170 · 2025
SOX4 promotes Ferroptosis to aggravate myocardial ischemia/reperfusion injury through elevating DAPK1 expression
10.1007/s12012-025-10072-w · 2025
Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target
10.1186/s43556-026-00420-9 · 2026
CARD9 promotes autophagy in cardiomyocytes in myocardial ischemia/reperfusion injury via interacting with Rubicon directly
10.1007/s00395-020-0790-6 · 2020
Suppression of OTUD4 protects against myocardial ischemia-reperfusion injury by increasing autophagic flux and inhibiting apoptosis in cardiomyocytes
10.1007/s00109-025-02605-1 · 2025
Nanoscale reference and test materials for the validation of characterization methods for engineered nanomaterials - current state, limitations, and needs
10.1007/s00216-024-05719-6 · doi-reference
Roadmap for commercial nanomedicine development: integrating quality by design principles with pharmaceutical nanotechnology
10.1021/acs.molpharmaceut.5c00056 · doi-reference
Regulatory considerations, challenges and risk-based approach in nanomedicine development
10.2174/0929867328666210406115529 · doi-reference
To PEGylate or not to PEGylate: immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
10.1016/j.addr.2021.114079 · doi-reference
Current hurdles to the translation of nanomedicines from bench to the clinic
10.1007/s13346-021-01024-2 · doi-reference
Integrated organosilica nanomedicine enables sonoimaging, sonochemistry and antitumor sonodynamic therapy
10.1177/08853282241258555 · doi-reference
Camptothecin-loaded and manganese dioxide-coated polydopamine nanomedicine used for magnetic resonance imaging diagnosis and chemo-photothermal therapy for lung cancer
10.2147/ijn.s359300 · doi-reference
Single doping for triple functions: integrated theranostic nanoplatforms for multimodal image-guided tumor therapy
10.1002/adhm.202301435 · doi-reference
PDT-sensitized ROS-responsive dextran nanosystem for maximizing antitumor potency of multi-target drugs
10.1016/j.ijpharm.2022.122567 · doi-reference
Stimuli-responsive carbon nanotubes for on-demand cancer therapy: a review
10.1208/s12249-026-03391-w · doi-reference
Advances in stimuli-responsive gold nanorods for drug-delivery and targeted therapy systems
10.1016/j.biopha.2024.117493 · doi-reference
A shear-responsive nanosystem engineered from fucoidan targets endothelial for atherosclerosis therapy
10.1016/j.biomaterials.2025.123931 · doi-reference
Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery
10.1126/sciadv.abo6163 · doi-reference
Anti-tumor metastasis via platelet inhibitor combined with Photothermal therapy under Activatable fluorescence/magnetic resonance bimodal imaging guidance
10.1021/acsami.1c02302 · doi-reference
Biomimetic targeted Nanoplatform exerts a combined effect of alleviating calcium overload and scavenging ROS to attenuate the inflammatory response in myocardial ischemia-reperfusion injury
10.1021/acsami.5c08306 · doi-reference
Strategic Design of Intelligent-Responsive Nanogel Carriers for Cancer therapy
10.1021/acsami.1c13634 · doi-reference
Single functional group platform for multistimuli responsivities: tertiary amine for CO2/pH/ROS-triggered cargo release in Nanocarriers
10.1021/acs.biomac.3c00434 · doi-reference
Mesenchymal stem cell-originated Exosomal Lnc A2M-AS1 alleviates hypoxia/reperfusion-induced apoptosis and oxidative stress in cardiomyocytes
10.1007/s10557-022-07339-7 · doi-reference
Engineered mesenchymal stem cells for targeted delivery of H2S to suppress cGAS-STING inflammation and enhance cardioprotection in myocardial ischemia-reperfusion
10.1016/j.jconrel.2025.114484 · doi-reference
Hierarchical structures of protein-Fiber-infused Aminoglycan hydrogels to promote myocardial repair
10.1021/acsnano.5c07064 · doi-reference
Time-released black phosphorus hydrogel accelerates myocardial repairing through antioxidant and motivates macrophage polarization properties
10.34133/bmr.0029 · doi-reference
Design of a Zn-based nanozyme injectable multifunctional hydrogel with ROS scavenging activity for myocardial infarction therapy
10.1016/j.actbio.2024.01.015 · doi-reference
Microfluidic manufacture of lipid-based nanomedicines
10.3390/pharmaceutics14091940 · doi-reference
Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury
10.1007/s10495-020-01602-8 · doi-reference
Ultrasound-targeted microbubble destruction-mediated Galectin-7-siRNA promotes the homing of bone marrow mesenchymal stem cells to alleviate acute myocardial infarction in rats
10.3892/ijmm.2020.4830 · doi-reference
Modified bFGF targeting connective tissue growth factor in the injured microenvironment improved cardiac repair after chronic myocardial ischemia
10.1016/j.reth.2025.01.006 · doi-reference
Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
10.1038/s41467-025-57048-6 · doi-reference
Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching
10.1038/s41401-023-01222-3 · doi-reference
Tissue-resident CCR2+ macrophage TREM-1/3 signaling is necessary for monocyte and neutrophil recruitment to injured hearts
10.1016/j.celrep.2025.115380 · doi-reference
Targeting mitochondrial shape: at the heart of cardioprotection
10.1007/s00395-023-01019-9 · doi-reference
The interplay between cardiac dyads and mitochondria regulated the calcium handling in cardiomyocytes
10.3389/fphys.2022.1013817 · doi-reference
FL3 mitigates cardiac ischemia-reperfusion injury by promoting mitochondrial fusion to restore calcium homeostasis
10.1038/s41420-025-02575-w · doi-reference
CLIC4 localizes to mitochondrial-associated membranes and mediates cardioprotection
10.1126/sciadv.abo1244 · doi-reference
Mitochondria-associated endoplasmic reticulum membranes and myocardial ischemia: from molecular mechanisms to therapeutic strategies
10.1186/s12967-025-06262-3 · doi-reference
Activation of sphingosine-1-phosphate receptors can relieve myocardial ischemia-reperfusion injury by mitigating oxidative stress and ferroptosis in cardiomyocytes
10.7150/ijbs.107402 · doi-reference
Self-assembling antioxidants for ischemia-reperfusion injuries
10.1089/ars.2021.0103 · doi-reference
VEGF mimetic peptide-conjugated nanoparticles for magnetic resonance imaging and therapy of myocardial infarction
10.1016/j.jconrel.2023.06.017 · doi-reference
VEGF mimetic peptide-modified bifunctional Nanosystem for targeted drug delivery in myocardial infarction
10.1021/acsabm.5c01922 · doi-reference
Theranostic contribution of extracellular matrix metalloprotease inducer-paramagnetic nanoparticles against acute myocardial infarction in a pig model of coronary ischemia-reperfusion
10.1161/circimaging.121.013379 · doi-reference
Organic nano-quantum dots of salvianolic acid B modified with photosensitive cypate for the diagnosis and treatment of myocardial ischemia-reperfusion injury
10.1016/j.colsurfb.2026.115414 · doi-reference